Coagulation Factor V Leiden Mutation Was Detected in the Patients with Activated Protein C Resistance in Thailand^[*]

 

^* This work was supported by the Japan Society for the Promotion of Science

• References

• 1 Garewal G, Das R, Trehan U. Factor V Leiden: Prevalence in indigenous population and cases of thrombosis in North India. Br J Haematol 1997; 97: 940.
• 2 Rees DC. The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 1996; 95: 579-86.
• 3 de Water NV, Williams R, Dare A, Abbott W, Browett P. The prevalence of factor V Leiden (Gln506) in Polynesians. Thromb Haemost 1997; 78: 962-3.
• 4 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
• 5 Ishida F, Ito T, Ichikawa N, Shimodaira S, Takamiya O, Furihata K, Kiyosawa K, Kitano K. Arg 506 Gln factor V mutation is uncommon in Eastern Asian populations. Blood 1995; 86: 917a.
• 6 Yiqun H, Jiang Z, Liwan X, Hongli W. Study of the relation between the FV Leiden mutation and Chinese APC resistance. Br J Haematol 1996; 93 (Suppl. 02) 3.
• 7 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22.
• 8 Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997; 96: 484-9.